Clinical Trials Browser

Phase 2 × Genetic Diseases, Inborn × Thalidomide × Clear all

NCT00020046 2023-10-31

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn